General Gastro News Articles

Gastro

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sarin SK et al. - For primary prophylaxis, a beta-blocker is effective in 38% and addition of ISMN raises the response rate to about half of patients. The HVPG-guided 'a la carte' approach may be considered for these patients.

Today in GI Bleeding...keeping you current

Active gastrointestinal bleeding: evaluation with contrast-enhanced ultrasonography
Abdominal Imaging , 11/25/09

Hemorrhagic Gastritis and Duodenitis Following Celiac Plexus Neurolysis
Pain Physician, 11/25/09

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09

Today in Pharmacology/kinetics...keeping you current

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09

Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
Cancer Chemotherapy and Pharmacology, 12/01/09